← Back
Data updated: Mar 29, 2026
ABLYNX NV
Pharmaceuticals
Biotech
ABLYNX NV is a biotechnology company with 1 FDA-approved products.
2019
Since
1
Drugs
-
Trials
3
Approved (2yr)
Key Drugs
No active drugs
Top Drug Revenues Pro
Loading...
Revenue Over Time Pro
Loading...
Recent Activity
SEC Filings
Pro
Loading...
Therapeutic Areas
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
No indication data
Pipeline Forecast
Loading...
Loading...
Upcoming Trial Milestones Pro
Loading...
Patent Cliff Pro
Loading...
Loading...
Loading...
Active (1)
Discontinued (0)
Company Info
- First Approval
- 2019-02-06
- Latest
- 2025-12-23
- Applications
- 1